Global Diabetes Devices Market 2010-2014

Countries covered: Global TechNavio's analysts forecast the Global Diabetes Devices market to reach US$20.5 billion in 2014. One of the key factors contributing to this market growth is the global increase in the diabetic population. The Global Diabetes Devices market has also been witnessing the latest insulin delivery systems. However, the process of registration of medical devices could be a challenge to the growth of this market. Key vendors dominating this market space include Roche Diagnostics, LifeScan Inc., Novo Nordisk Inc. and Bayer Diabetes Care. TechNavio's Global Diabetes Devices Market 2010-2014 has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions, and covers the details of the glucose monitoring devices and insulin delivery devices. Key questions answered in this report: What will the market size be in 2014 and at what rate will it grow? What key trends is this market subject to? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the opportunities and threats faced by each of these key vendors? What are the strengths and weaknesses of each of these key vendors?

Additional Information


Press Release

TechNavio Announces the Publication of its Report - Global Diabetes Devices Market 2010-2014

TechNavio today launched its Global Diabetes Devices Market 2010-2014 report based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aids decision makers’ understanding of the key trends impacting the growth of this market.

Commenting on the report, an analyst from TechNavio’s Healthcare team said, “The increasing demand for non-invasive devices is leading to the development of new technologies in the Global Diabetes Devices market. The devices that are currently in development use sweat, exhaled breath or a fluorescent signal to measure a patient’s blood glucose level, eliminating the painful process of piercing the skin to collect a blood sample for measurement with the current devices. With the application of new technologies, these devices are expected to be more efficacious and reduce errors compared to the currently marketed products.”

According to the report, previously the prices of the diabetes devices were high and were not affordable by the low- and middle-income population. But lately, due to the emergence of modern devices, the prices have reduced up to 50-60 percent, and many patients are now able to afford them, which has driven the market significantly. This driver is expected to have a strong impact on the market.

The report also discusses challenges with accuracy variations over time.

The study was carried out using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.

TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit www.technavio.com.

TechNavio today launched its Global Diabetes Devices Market 2010-2014 report based on an in-depth study covering on the Americas, and the EMEA and APAC regions. The report aids decision makers’ understanding of the key trends impacting the growth of this market.

Commenting on the report, an analyst from TechNavio’s Healthcare team said, “The increasing demand for non-invasive devices is leading to the development of new technologies in the Global Diabetes Devices market. The devices that are currently in development use sweat, exhaled breath or a fluorescent signal to measure a patient’s blood glucose level, eliminating the painful process of piercing the skin to collect a blood sample for measurement with the current devices. With the application of new technologies, these devices are expected to be more efficacious and reduce errors compared to the currently marketed products.”

According to the report, previously the prices of the diabetes devices were high and were not affordable by the low- and middle-income population. But lately, due to the emergence of modern devices, the prices have reduced up to 50-60 percent, and many patients are now able to afford them, which has driven the market significantly. This driver is expected to have a strong impact on the market.

The report also discusses challenges with accuracy variations over time.

The study was carried out using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.

More Global Diabetes Reports

Insulin - Top 10 Global Markets by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 10 global markets. ...

Insulin - Global by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in global markets. The analyses ...

Global Continuous Glucose Monitoring Device Market 2011-2015 by Infiniti Research Limited
TechNavio’s analysts forecast the the Global Continuous Glucose Monitoring Device market to grow at a CAGR of 11.5 percent over the period 2011–2015. One of ...

Global Glucose Monitoring Market Report: 2012 Edition by Koncept Analytics
The worldwide market for blood glucose monitoring is mainly dependent on the number of diabetes patients in the world which is growing significantly and is ...

Analyzing the Global Diabetes Market by Aruvian's R'search
Diabetes is a chronic disease in which there are high levels of sugar in the blood. The World Diabetes Foundation estimates that there will be ...

See all reports like this >>